生物标志物分析的规范:在诊所可以翻译什么?
Marios A Diamantopoulos1, Michaela A Boti1, Triantafyllia Sarri1
1Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Athens, Greece.
Expert review of molecular diagnostics
|August 6, 2025
概括
生物标志物监管正随着人工智能和精密医学的多种omics而发展. 克服挑战和促进全球合作是成功临床实施和改善患者护理的关键.
科学领域:
- 生物标志物的发现和验证.
- 精准医学是一门精准的医学.
- 监管科学是一种监管科学.
背景情况:
- 生物标志物在精准医学中对于疾病检测,治疗指导和结果预测至关重要.
- 通过实现个性化的方法,它们改善了患者护理,并降低了医疗保健成本.
研究的目的:
- 审查生物标志物开发和实用性的监管环境.
- 确定生物标志物翻译方面的挑战,并提出解决方案.
- 讨论生物标志物监管的未来趋势,包括人工智能和多omics.
主要方法:
- 来自主要机构的监管框架的综合文献审查.
- 对生物标志物翻译的挑战和建议的分析.
- 探索新兴趋势,如人工智能和多omics.
主要成果:
- 目前的监管框架指导生物标志物从研究到临床应用.
- 生物标志物翻译的关键挑战包括技术,伦理和验证障碍.
- 未来的趋势表明适应性监管框架,人工智能集成和高通量方法.
结论:
- 未来的生物标志物监管可能将涉及适应性框架,人工智能和高通量方法.
- 严格的验证,伦理考虑和质量控制对于临床成功至关重要.
- 为了有效实施生物标志物,需要加强利益相关者之间的全球合作.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Regulation of Expression at Multiple Steps
1.0K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.0K
Clinical Trials
8.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Translational Regulation
94
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
94


